Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
Cardiac hypertrophy increases the risk of morbidity and mortality of cardiovascular disease and thus inhibiting such hypertrophy is beneficial. In the present study, we explored the effect of a bioactive peptide (PAP) on angiotensin II (Ang II)-induced hypertrophy and associated ventricular arrhythm...
Main Authors: | Rui Wang, Yanwen Wang, Wee K Lin, Yanmin Zhang, Wei Liu, Kai Huang, Derek A Terrar, R John Solaro, Xin Wang, Yunbo Ke, Ming Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4094434?pdf=render |
Similar Items
-
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation
by: Yunbo Ke, et al.
Published: (2008-08-01) -
Left ventricular hypertrophy in arterial hypertension and arrhythmia risk
by: I. G. Fomina, et al.
Published: (1970-01-01) -
Bioactive angiotensin peptides: focus on angiotensin IV
by: Tomris Mustafa, et al.
Published: (2001-12-01) -
Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling
by: Yunbo eKe, et al.
Published: (2013-09-01) -
LEFT VENTRICULAR HYPERTROPHY AND LEFT ATRIAL DILATATION AS MARKERS OF MALIGNANT ARRHYTHMIAS DEVELOPMENT
by: Yuliia Shushkovska, et al.
Published: (2019-12-01)